Found: 11
Select item for more details and to access through your institution.
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer.
- Published in:
- Cancer & Metabolism, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40170-021-00270-9
- By:
- Publication type:
- Article
In Vivo Analysis of a Gain-of-Function Mutation in the Drosophila eag-Encoded K<sup>+</sup> Channel.
- Published in:
- Genetics, 2006, v. 172, n. 4, p. 2351, doi. 10.1534/genetics.105.048777
- By:
- Publication type:
- Article
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Nitric Oxide Synthase Inhibition Enhances the Antitumor Effect of Radiation in the Treatment of Squamous Carcinoma Xenografts.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020147
- By:
- Publication type:
- Article
Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 239, doi. 10.3390/cancers11020239
- By:
- Publication type:
- Article
Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234505
- By:
- Publication type:
- Article
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152584
- By:
- Publication type:
- Article
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Poly ADP‐ribose polymerase‐1 as a potential therapeutic target in Merkel cell carcinoma.
- Published in:
- Head & Neck, 2018, v. 40, n. 8, p. 1676, doi. 10.1002/hed.25146
- By:
- Publication type:
- Article
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02332-2
- By:
- Publication type:
- Article